Can you predict a man’s risk of prostate cancer 25 years in the future? The data from this study indicates that PSA levels before age 50 is an indicator of future prostate cancer. Find out more about the prospective study conducted by a team of researchers from Memorial Sloane Kettering. Epidemiologist Andrew Vickers talks with host Dr. Bill Rutenberg about what the GP can take from this study What does a slightly elevated, but not high PSA indicate about the chance of prostate cancer in the future?
Prostate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Can you predict a man’s risk of prostate cancer 25 years in the future? The data from this study indicates that PSA levels before age 50 is an indicator of future prostate cancer. Find out more about the prospective study conducted by a team of researchers from Memorial Sloane Kettering. Epidemiologist Andrew Vickers talks with host Dr. Bill Rutenberg about what the GP can take from this study What does a slightly elevated, but not high PSA indicate about the chance of prostate cancer in the future?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Updates From the 7th World Symposium Task Force
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?